tirzepatide regulations fda and π’Important FDA Update on Compounded Tirzepatide! Due to recent FDA regulations, the Tirzepatide for Medical Weight Loss
Description
Participants included adults who had been using GLP-1 for at least three months
A patient-friendly comparison of Compounded Semaglutide and Compounded Tirzepatide, including how they work and how clinicians think about options.
For now, the tension between innovation and compliance remains a defining feature of the GLP-1 landscape
The first cohort included 6696 patients who started GLP-1 receptor agonists and added on SGLT-2 inhibitors, and the second included 8942 patients who started SGLT-2 inhibitors and added on GLP-1 receptor agonists
